MeMed Diagnostics Ltd. (“MeMed”) has created a platform for discovery, development and validation of novel diagnostic solutions aimed at improving the management of patients with infectious diseases and inflammatory disorders. The platform relies on a combination of molecular and cellular immunology, bioinformatics, big data analysis and clinical knowledge. MeMed’s products provide physicians with critical, timely information that supports decision making on the treatment of patients.